Talya Salant, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Efficiency, Organizational | 1 | 2013 | 695 | 0.310 |
Why?
|
| Attitude to Health | 2 | 2008 | 2024 | 0.300 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1505 | 0.260 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 940 | 0.240 |
Why?
|
| Marketing of Health Services | 1 | 2005 | 150 | 0.240 |
Why?
|
| Ovariectomy | 1 | 2006 | 613 | 0.230 |
Why?
|
| Crime Victims | 1 | 2008 | 347 | 0.220 |
Why?
|
| Acculturation | 1 | 2003 | 178 | 0.200 |
Why?
|
| Primary Health Care | 5 | 2024 | 4673 | 0.180 |
Why?
|
| Emigration and Immigration | 1 | 2003 | 397 | 0.180 |
Why?
|
| Choice Behavior | 1 | 2006 | 824 | 0.170 |
Why?
|
| Developed Countries | 1 | 2003 | 448 | 0.170 |
Why?
|
| Chicago | 3 | 2008 | 254 | 0.150 |
Why?
|
| Referral and Consultation | 4 | 2023 | 3603 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 1116 | 0.130 |
Why?
|
| Bariatric Surgery | 1 | 2005 | 991 | 0.130 |
Why?
|
| Colonoscopy | 1 | 2023 | 1398 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2008 | 20981 | 0.120 |
Why?
|
| Internet | 1 | 2005 | 3094 | 0.110 |
Why?
|
| Dermatology | 1 | 2022 | 918 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 254 | 0.090 |
Why?
|
| Health Status | 1 | 2003 | 4077 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2008 | 24013 | 0.080 |
Why?
|
| Organizational Culture | 1 | 2013 | 509 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 3197 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12145 | 0.080 |
Why?
|
| Telemedicine | 1 | 2023 | 3051 | 0.070 |
Why?
|
| Hospitals, Public | 1 | 2006 | 201 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 17889 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2023 | 5879 | 0.050 |
Why?
|
| Obesity | 1 | 2005 | 12937 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5809 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2013 | 3016 | 0.050 |
Why?
|
| Focus Groups | 1 | 2008 | 1409 | 0.050 |
Why?
|
| Asia | 1 | 2003 | 621 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2006 | 856 | 0.050 |
Why?
|
| Reading | 1 | 2024 | 531 | 0.040 |
Why?
|
| Calcaneus | 1 | 2001 | 142 | 0.040 |
Why?
|
| Pedigree | 1 | 2006 | 4537 | 0.040 |
Why?
|
| Mental Health | 1 | 2013 | 3251 | 0.040 |
Why?
|
| Memory | 1 | 2008 | 2190 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2024 | 787 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2024 | 80673 | 0.040 |
Why?
|
| Survivors | 1 | 2008 | 2369 | 0.040 |
Why?
|
| Humans | 14 | 2024 | 761098 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 850 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2008 | 1846 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20120 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 2757 | 0.030 |
Why?
|
| Decision Making | 1 | 2006 | 3925 | 0.030 |
Why?
|
| Software | 1 | 2006 | 4433 | 0.030 |
Why?
|
| Choriocarcinoma | 1 | 1992 | 121 | 0.020 |
Why?
|
| Boston | 1 | 2023 | 9324 | 0.020 |
Why?
|
| Female | 6 | 2023 | 392458 | 0.020 |
Why?
|
| Risk Factors | 3 | 2006 | 74219 | 0.020 |
Why?
|
| Aged | 4 | 2023 | 169266 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 21357 | 0.020 |
Why?
|
| Bone Density | 1 | 2001 | 3548 | 0.020 |
Why?
|
| Adult | 4 | 2023 | 221083 | 0.020 |
Why?
|
| Middle Aged | 4 | 2023 | 220835 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4813 | 0.020 |
Why?
|
| Time Factors | 1 | 2023 | 39953 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2001 | 114 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 368 | 0.010 |
Why?
|
| United States | 1 | 2005 | 72337 | 0.010 |
Why?
|
| Anthropometry | 1 | 2001 | 1338 | 0.010 |
Why?
|
| Male | 2 | 2023 | 360675 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 221 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1992 | 457 | 0.010 |
Why?
|
| Life Style | 1 | 2001 | 3908 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 5971 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 1743 | 0.000 |
Why?
|
| Methotrexate | 1 | 1992 | 1717 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 6123 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 26068 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1992 | 12743 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 58946 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1992 | 11505 | 0.000 |
Why?
|